Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

8.00
-0.2100-2.56%
Volume:73.81K
Turnover:594.81K
Market Cap:136.84M
PE:-2.07
High:8.22
Open:8.22
Low:8.00
Close:8.21
52wk High:16.77
52wk Low:7.63
Shares:17.11M
Float Shares:15.72M
Volume Ratio:1.55
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:0.64
PE(LYR):-2.51

Loading ...

Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference

GlobeNewswire
·
2 hours ago

Atrium Therapeutics Corrects Post-Offering Shares Outstanding to 21,571,507

Reuters
·
Oct 09

US Stocks on the MOVE-Palantir, Haemonetics

Reuters
·
Oct 09

Atrium Therapeutics Rallies After $50 Mln Equity Raise

Reuters
·
Oct 08

Atrium Therapeutics announces $50M private placement

TIPRANKS
·
Oct 08

Atrium Therapeutics Prices USD 50 Million Private Placement at USD 7.93 Per Share

Reuters
·
Oct 08

Atrium Therapeutics Announces $50 Million Private Placement

THOMSON REUTERS
·
Oct 08

Atrium Therapeutics - Net Proceeds and Existing Cash Expected to Fund Operations Through 2028

THOMSON REUTERS
·
Oct 08

PacBio, TychoBio collaborate to generate full-length RNA data

TIPRANKS
·
Oct 06

Cerenome Launches CNSide® CSF Molecular Profile Tests

GlobeNewswire
·
Oct 06

Abogen announces licensing, option agreement with Novartis

TIPRANKS
·
Oct 02

Press Release: Wave Life Sciences Announces GSK's Selection of siRNA Program to Transition to GSK for Further Development

Dow Jones
·
Sep 30

ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor

GlobeNewswire
·
Sep 23

Press Release: Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer

Dow Jones
·
Sep 22

Atrium Therapeutics Awards New Hire Options for 13,500 Shares, RSUs for 6,750 Shares Under Inducement Plan

Reuters
·
Sep 22

Atrium Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 22

Alzheimer’s-Fighting ADARx Pharmaceuticals Set for Near $2B IPO

TIPRANKS
·
Sep 21

FMC, AgroSpheres advance bioinsecticide pipeline into field trials

TIPRANKS
·
Sep 17

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

GlobeNewswire
·
Sep 09